Black Diamond Therapeutics, Inc.· BDTX

🇺🇸 US · MicroBroad USNASDAQ

Healthcare Biotechnology Website

Price: $2.10
Day: -0.94%
Mkt Cap: $120.33M
52W Range: $1.60 – $4.94
Volume: 366.7K
Beta: 3.31

D55D FrameworkQuarterly Data

Holdings Analysis

Insider activity, institutional flows, and fund ownership.

Smart Money: 3.1 / 5 (Neutral), from 2 of 3 components
Institutions Q2 2026: 103 institutions hold; 65 added, 23 reduced

Blog

stockoscope.com

Black Diamond Therapeutics, Inc.

BDTX|Healthcare|Biotechnology

Current price: $2

Smart Money

Dimension 5 of 5

Insider selling pace · Q1 2025

130x

vs own 6-quarter average

Seller breadth · Q1 2025

1 seller

vs 0.3 avg per quarter

Institutional net breadth · Q2 2026

+38

93 adding vs 55 reducing

Institutional ownership · Q2 2026

61.4%

103 institutions

Insider Selling Pace

Each quarter's selling vs this stock's own trailing 6-quarter average

Light <0.5xRoutineElevated >1.5xHeavy >3xBuying

Institutional Positions

Institutions adding above the line, reducing below, net as a line

NewIncreasedReducedClosedNet

Largest Institutional Holders, Q2 2026

By reported market value, and how each moved in the quarter

Holder

Change

NEA MANAGEMENT COMPANY, LLC

4.4M

-0.2%

T. ROWE PRICE INVESTMENT MANAGEMENT, INC.

4.0M

-62.0%

BLACKROCK, INC.

3.9M

+253.1%

ACADIAN ASSET MANAGEMENT LLC

2.3M

-0.2%

VANGUARD CAPITAL MANAGEMENT LLC

2.1M

+14.6%

RENAISSANCE TECHNOLOGIES LLC

2.0M

+19.1%

ETF & Fund Activity, Q2 2026

How the covering funds split between buying, holding and selling

26 buying98 unchanged16 selling

140 funds held BDTX in Q2 2026, holding 27.3M shares between them, up 7.3% on the quarter.

Largest fund holders

VANGUARD VALLEY FORGE FUNDS27.0K sh

Brighthouse Funds Trust I24.5K sh

ALLSPRING VARIABLE TRUST23.5K sh

Notable Insider Transactions, Q1 2025

Largest open-market purchases and sales by value in the last eight quarters

Sale · Mar 19

BIOTECH GROWTH N V

$4.0M

Sale · Mar 19

BIOTECH GROWTH N V

$2.3M

Sale · Mar 19

BIOTECH GROWTH N V

$1.1M

Insider transactions from SEC Form 4 filings; institutional holdings from quarterly 13F filings, which are reported with a lag and can overlap between filers. 13F: quarterly institutional holdings report · ETF: Exchange-Traded Fund

See the complete picture

The full 5D Framework: Business Quality · Peer Comparison · Valuation · Analyst Sentiment · Smart Money

Explore BDTX on stockoscope.com→

Generated September 9, 2026

For educational purposes only. Not financial advice. Data may be delayed or incomplete.

Smart Money Sentiment

BDTX Smart Money Sentiment Score

A weighted 1-5 sentiment score across three smart money signals.

Smart Money

3.1/5

Neutral

Weighted across 3 components

Component Breakdown (2 of 3 available)

Insider Activity

40% weight

No data

Institutional Flow

50% weight

Fund Flow

10% weight

+25

Overall Smart Money sentiment of 3.1/5 (Neutral) based on a weighted combination of 2 components. Insider activity uses a relative-baseline comparison against the stock's own history; institutional flow tracks position momentum and 13F share changes; fund flow measures ETF / mutual-fund buying vs selling. Higher scores indicate stronger bullish sentiment from professional investors.Last updated September 9, 2026.

Insider Trading Activity

Insider trading analysis comparing the latest quarter against the stock's own historical baseline.

Insider Selling Pace for BDTX

Each quarter's selling vs the stock's own trailing 6-quarter average; 1.0x is typical for this stock. Green triangles mark quarters with insider buying.

No Data

No recent insider signal

Most recent insider filing was Q1 2025.

Notable Recent Transactions, BDTX

Top 6 highest-value insider trades from the last 8 quarters

BIOTECH GROWTH N V

10% Owner

Sell

2,000,000 shares at $2.00

≈32.2% of their stake at the time

Mar 19, 2025$4.00M

BIOTECH GROWTH N V

10% Owner

Sell

1,000,000 shares at $2.31

≈13.9% of their stake at the time

Mar 19, 2025$2.31M

BIOTECH GROWTH N V

10% Owner

Sell

584,292 shares at $1.95

≈15.3% of their stake at the time

Mar 19, 2025$1.14M

BIOTECH GROWTH N V

10% Owner

Sell

500,000 shares at $2.12

≈15.5% of their stake at the time

Mar 19, 2025$1.06M

BIOTECH GROWTH N V

10% Owner

Sell

400,000 shares at $2.09

≈9.5% of their stake at the time

Mar 19, 2025$837.16K

BIOTECH GROWTH N V

10% Owner

Sell

300,000 shares at $1.94

≈4.0% of their stake at the time

Mar 19, 2025$582.90K

Institutional Ownership Analysis

Institutional ownership analysis with position momentum, 13F share flow, and ownership percentage trends.

Institutional Positions for BDTX

Institutions adding (new + increased) above zero, reducing (reduced + closed) below, net as a line

New Increased Reduced Closed Net (adding − reducing)

Neutral

Mixed institutional activity in Q2 2026

61.4% institutional ownership

Moderate accumulation: 93 adding vs 55 reducing

13F shares decreased by 9.4%, a significant shift

Momentum improving from prior quarter

+38

Net breadth

93 adding vs 55 reducing

Accumulating

1.69

Add / reduce ratio

in Q2 2026

-4

New − closed

28 initiated, 32 exited

7 of 10

Top holders adding

largest holders that added

Position Changes

Q2 2026: how are institutions adjusting their positions?

+93 growing-55 shrinkingNet: +38

New (28)

Increased (65)

Reduced (23)

Closed (32)

Top Institutional Holders, BDTX

Largest 8 institutional positions by ownership percentage as of Q2 2026

NEA MANAGEMENT COMPANY, LLC

4.4M

$8.2M

Ownership

7.75%

-0.2%

T. ROWE PRICE INVESTMENT MANAGEMENT, INC.

4.0M

$7.5M

Ownership

7.02%

-62.0%

BLACKROCK, INC.

3.9M

$7.2M

Ownership

6.83%

+253.1%

ACADIAN ASSET MANAGEMENT LLC

2.3M

$4.3M

Ownership

4.09%

-0.2%

VANGUARD CAPITAL MANAGEMENT LLC

2.1M

$3.9M

Ownership

3.70%

+14.6%

RENAISSANCE TECHNOLOGIES LLC

2.0M

$3.6M

Ownership

3.42%

+19.1%

DEFILADE CAPITAL MANAGEMENT, L.P.

1.7M

$3.1M

Ownership

2.92%

+100.0%

DIMENSIONAL FUND ADVISORS LP

1.4M

$2.5M

Ownership

2.38%

+4.7%

ETF and Mutual Fund Holdings

ETF and mutual fund activity breakdown showing buying vs selling funds, top fund holders, and detailed holdings.

Fund Activity

Q2 2026: 140 ETFs and mutual funds reporting

26 buying16 sellingNet: +10

Buying (26)

Unchanged (98)

Selling (16)

In total, funds bought 2.7M shares and sold 734.8K this quarter. Each fund counts once in the bar above, whatever the size of its move.

Bullish Signal

Funds accumulating in Q2 2026

140 ETFs and mutual funds reporting

26 funds buying vs 16 selling

Top Fund Holders, BDTX

Largest 8 ETF and mutual fund positions by shares held, each fund's latest filing

VANGUARD VALLEY FORGE FUNDS

27.0K

Weight

25.04%

Jun 30, 2026No change

Brighthouse Funds Trust I

24.5K

Weight

0.00%

Jun 30, 2026No change

ALLSPRING VARIABLE TRUST

23.5K

Weight

4.64%

Jun 30, 2026No change

VARIABLE INSURANCE PRODUCTS FUND IV

22.3K

Weight

0.44%

Jun 30, 2026No change

PACIFIC SELECT FUND

22.0K

Weight

0.00%

Jun 30, 2026Increased

NORTHERN FUNDS

21.8K

Weight

0.02%

Jun 30, 2026Decreased

GOLDMAN SACHS TRUST

20.2K

Weight

0.00%

Jun 30, 2026Decreased

VARIABLE INSURANCE PRODUCTS FUND III

19.7K

Weight

0.26%

Jun 30, 2026No change

Black Diamond Therapeutics, Inc.· BDTX

Holdings Analysis

Insider Trading Activity

1.3Transaction History175Real market purchases and sales onlyShow All Types

Institutional Ownership Analysis

2.4Detailed Holdings25Most recent institutional positions with changes and valuations

ETF and Mutual Fund Holdings

3.3Fund Holdings Details25Most recent ETF and mutual fund holdings with share counts and weights

Search stocks

Holdings Analysis

Insider Trading Activity

1.3Transaction History175Real market purchases and sales onlyShow All Types

Institutional Ownership Analysis

2.4Detailed Holdings25Most recent institutional positions with changes and valuations

ETF and Mutual Fund Holdings

3.3Fund Holdings Details25Most recent ETF and mutual fund holdings with share counts and weights